A UK research team has developed a pioneering blood test that could change the way lung cancer is detected and monitored.
Two major Dutch hospitals, Catharina Ziekenhuis in Eindhoven and University Medical Center (UMC) Utrecht, are integrating ...
NeXT Personal identifies circulating tumor DNA in 81% of early-stage lung adenocarcinoma cases, offering potential for better disease stratification and outcome prediction. Study: Ultrasensitive ctDNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback